AbbVie, Endo Deceived Men About Testosterone Gel, Suit Says

Law360, New York (December 4, 2015, 7:09 PM EST) -- A Florida man who had two heart attacks he says were caused by prescription testosterone gels made by pharmaceutical companies AbbVie and Endo sued the drugmakers in Pennsylvania state court, alleging they failed to warn him and a proposed class of the gel's negative effects.

Abbie Inc., the maker of AndroGel, and Endo Pharmaceuticals, which now makes Testim after acquiring Auxilium Pharmaceuticals Inc. in January, engaged in massive advertising campaigns that led customers to believe that natural effects of aging in men were actually symptoms of low testosterone and could be treated with their products, according to a complaint filed by...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!